Overview

Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of two different kinds of diabetes medications, insulin detemir (Levemir) and exenatide (Byetta), in improving blood sugar levels with little or no weight gain in patients with type 2 diabetes who are not well controlled on two or more oral (by mouth) diabetes medications. Both medications are given by injection with a very small needle just below the surface of your skin (called subcutaneous injection). The medication that you inject will be in addition to your oral medications.
Phase:
Phase 4
Details
Lead Sponsor:
Novo Nordisk A/S
Collaborator:
BodyMedia
Treatments:
Exenatide
Insulin
Insulin Detemir
Insulin, Globin Zinc